OR WAIT null SECS
February 03, 2022
In this study, researchers evaluated the colloidal microcrystalline cellulose (cMCC) suspending agent—a co-processed material of microcrystalline cellulose and sodium carboxymethyl cellulose (NaCMC)—by using a representative pharmaceutical-grade commercial version of cMCC.
February 02, 2022
The global nature of the COVID-19 pandemic emphasizes the critical importance of expanded vaccination.
Toxicology studies are an important and required aspect of drug development that are performed to ensure that drugs are deemed safe prior to patient administration and use in clinical trials.
February 01, 2022
Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.
A key benefit for companies when outsourcing formulation development is the broad experience they can gain from a dedicated service provider, particularly for niche markets.
January 28, 2022
Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.
Catalent has expanded its Malvern, Pennsylvania, USA, and Dartford, UK, facilities to provide advanced containment capabilities for the micronization of highly potent drug compounds.
January 27, 2022
Stevanato Group has extended its licensing agreement with Haselmeier for its Axis-D pen injector technology.
January 21, 2022
A report by international regulators reviews the effectiveness of current COVID-19 vaccines against the omicron variant.
January 17, 2022
Protective external packaging ensures COVID-19 vaccines arrive safely.
